Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

MLA

Brunkhorst FM, et al. “Effect of Empirical Treatment with Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients with Severe Sepsis: A Randomized Trial.” JAMA: Journal of the American Medical Association, vol. 307, no. 22, June 2012, pp. 2390–99. EBSCOhost, https://doi.org/10.1001/jama.2012.5833.

APA

Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, Jaschinski U, Meier-Hellmann A, Weyland A, Gründling M, Moerer O, Riessen R, Seibel A, Ragaller M, Büchler MW, John S, Bach F, Spies C, & Reill L. (2012). Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA: Journal of the American Medical Association, 307(22), 2390–2399. https://doi.org/10.1001/jama.2012.5833

Chicago

Brunkhorst FM, Oppert M, Marx G, Bloos F, Ludewig K, Putensen C, Nierhaus A, et al. 2012. “Effect of Empirical Treatment with Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients with Severe Sepsis: A Randomized Trial.” JAMA: Journal of the American Medical Association 307 (22): 2390–99. doi:10.1001/jama.2012.5833.